Molecular farming company Nexus Agriscience has acquired the hemp division of cannabis intellectual property company Biotech Institute, expanding its molecular farming platform by internalizing core genetics and research capabilities.
The patent portfolio protects genetic pathways and proprietary germplasm that enable predictable expression of high-value compounds across the primary terpene classes found within the cannabis genome.
"This acquisition expands our platform and removes critical constraints," said Shareef El-Sissi, CEO of Nexus Agriscience. "By bringing core genetics and R&D in-house, we can move faster into new markets while maintaining the capital efficiency and scalability that define our approach. The cannabis plant is the most prolific natural producer of flavor and fragrance compounds, and this portfolio gives us the tools to express those compounds predictably and at commercial scale."
Dr. Mark Lewis, one of the key inventors on the acquired patents, said, "Hemp is an extraordinarily powerful biosynthetic platform when engineered with precision turning plants into factories. This portfolio distills years of genomic, chemical, and breeding work into predictable expression of high-value compounds, accelerating the transition from fundamental science to scalable manufacturing."
For more information:
Nexus Agriscience
https://nexusagriscience.com/
